BB Biotech — A key milestone with significance for the sector

Wave is a US-based clinical-stage biotechnology company that designs and develops ribonucleic acid (RNA) medicines through its discovery and drug development platform, PRISM. This platform combines multiple modalities, chemistry innovation and deep knowledge of human genetics, with the intention of delivering and commercialising scientific breakthroughs that treat both rare and prevalent disorders.